Research Sometimes Tumors Vanish, but Improvements Still Needed for CAR T-Cell Immunotherapy By Leslie Orr Nov. 19, 2020 Patrick Reagan, M.D., looks at the data on his computer screen and a rare grin spreads across his face. His most recent study results for patients with end-stage mantle cell lymphoma show that an ...
Patient Care CAR T-cell Therapy: 'Research and Amazing Medicine' By Leslie Orr Nov. 18, 2020 In autumn of 2017, Nicole Zaleski-Conine experienced side effects she chalked up to a host of reasons, but in January 2018, the definitive diagnosis came in: follicular lymphoma that transformed into ...
Patient Care CAR T-cell Therapy: Finally, a Milestone to Celebrate By Leslie Orr Nov. 18, 2020 Maxine and Dave Wilson finish each other’s sentences. They feel blessed to have each other, given what Maxine has been through. Then, Maxine was unexpectedly diagnosed with non-Hodgkin lymphoma in ...
Patient Care CAR T-cell Therapy: The Doctor is a Patient By Leslie Orr Nov. 18, 2020 Patrick Brophy, M.D., physician-in-chief at UR Medicine Golisano Children’s Hospital, says he never looked at his own medical chart. But he knew his health was declining rapidly.
Research Shingles Vaccine Shows Promise in Lymphoma Patients By Leslie Orr Nov. 10, 2020 New research gives a thumbs up to offering the shingles vaccine to lymphoma patients, who were often not eligible in the past.
Patient Care Watch for Wilmot during 2019 Super Bowl By Ruth Harper-Rhode Jan. 31, 2019 UR Medicine’s Wilmot Cancer Institute will be featured in a commercial that will air during the 2019 Super Bowl, which starts at 6:30 p.m. on Sunday, Feb. 3. The ad highlights several key facts about ...
Research Melanoma Linked with CLL, Wilmot Recommends Close Monitoring By Leslie Orr Aug. 13, 2018 While studying a large group of individuals with chronic lymphocytic leukemia (CLL), a Wilmot Cancer Institute scientific team made an important discovery — these patients had a sizable 600 percent ...
Research Wilmot Scientists Reap Awards, Presentations at Hematology Meeting By Leslie Orr Dec. 7, 2017 Wilmot Cancer Institute has a longstanding strength in the study of blood cancers—and from Dec. 9-12, many of our scientists will be presenting research at the 59th annual meeting of the American ...
Research FDA Approves Landmark Cancer Therapy; Wilmot Among First to Offer It By Leslie Orr Oct. 20, 2017 UR Medicine’s Wilmot Cancer Institute will be among the first sites in the world to offer CAR T-cell therapy —a new type of immunotherapy—to adults with aggressive lymphoma. The engineered gene ...
Research In Lifetime of Achievement, URMC Hematologist is Grateful for Opportunities, Longevity By Leslie Orr Aug. 24, 2017 Marshall A. Lichtman, M.D., a University of Rochester hematologist/oncologist and former dean of the School of Medicine and Dentistry, will receive one of the highest honors in his field from the ...
